Sökning: WFRF:(Bonfim C) >
Outcomes after Hapl...
Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
-
Fernandes, J. F. (författare)
-
Nichele, S. (författare)
-
Arcuri, L. J. (författare)
-
visa fler...
-
Ribeiro, L. (författare)
-
Zamperlini-Netto, G. (författare)
-
Loth, G. (författare)
-
Rodrigues, A. L. M. (författare)
-
Kuwahara, C. (författare)
-
Koliski, A. (författare)
-
Trennepohl, J. (författare)
-
Garcia, J. L. (författare)
-
Daudt, L. E. (författare)
-
Seber, A. (författare)
-
Gomes, A. A. (författare)
-
- Fasth, Anders, 1945 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics
-
Pasquini, R. (författare)
-
Hamerschlak, N. (författare)
-
Rocha, V. (författare)
-
Bonfim, C. (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2020
- 2020
- Engelska.
-
Ingår i: Biology of Blood and Marrow Transplantation. - : Elsevier BV. - 1083-8791. ; 26:10, s. 1923-1929
- Relaterad länk:
-
http://www.astctjour...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Allogeneic hematopoietic stem cell transplantation (HCT) can cure primary immunodeficiency diseases (PID). When a HLA-matched donor is not available, a haploidentical family donor may be considered. The use of T cell-replete haploidentical HCT with post-transplantation cyclophosphamide (haplo-PTCy) in children with PID has been reported in few case series. A donor is usually readily available, and haplo-PTCy can be used in urgent cases. We studied the outcomes of 73 patients with PID who underwent haplo-PTCy, including 55 patients who did so as a first transplantation and 18 who did so as a salvage transplantation after graft failure of previous HCT. The median patient age was 1.6 years. Most of the children were male (n = 54) and had active infection at the time of transplantation (n = 50); 10 children had severe organ damage. The diagnosis was severe combined immunodeficiency (SCID) in 34 patients and non-SCID in 39 (Wiskott-Aldrich syndrome; n = 14; chronic granulomatous disease, n = 10; other PID, n = 15). The median duration of follow-up of survivors was 2 years. The cumulative incidence of neutrophil recovery was 88% in the SCID group and 84% in non-SCID group and was 81% for first transplantations and 83% after a salvage graft. At 100 days, the cumulative incidence of acute GVHD grade II-IV and III-IV was 33% and 14%, respectively. The majority of patients reached 200/mu L CD4(+) and 1000/mu L CD3(+) cell counts between 3 and 6 months. The estimated 2-year overall survival was 66%; it was 64% for SCID patients and 65% for non-SCID patients and 63% for first HCT and 77% for salvage transplantations. Twenty-five patients died, most of them due to infection early after transplantation (before 100 days). In conclusion, haplo-PTCy is a feasible procedure, can cure two-thirds of children with PID, and can be used as rescue treatment for previous graft failure. (C) 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. (c) 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Nyckelord
- Haploidentical transplantation
- Post-transplantation cyclophosphamide
- Primary immunodeficiency disease
- Outcomes
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Fernandes, J. F.
-
Nichele, S.
-
Arcuri, L. J.
-
Ribeiro, L.
-
Zamperlini-Netto ...
-
Loth, G.
-
visa fler...
-
Rodrigues, A. L. ...
-
Kuwahara, C.
-
Koliski, A.
-
Trennepohl, J.
-
Garcia, J. L.
-
Daudt, L. E.
-
Seber, A.
-
Gomes, A. A.
-
Fasth, Anders, 1 ...
-
Pasquini, R.
-
Hamerschlak, N.
-
Rocha, V.
-
Bonfim, C.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Pediatrik
- Artiklar i publikationen
-
Biology of Blood ...
- Av lärosätet
-
Göteborgs universitet